Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

December 2022 Issue of The Medicine Maker

Join us in celebrating the 2022 Innovation Awards that showcase the top drug development and manufacturing technologies of the year! In My View articles this issue cover best practices for embracing digitization and words of wisdom on mRNA manufacturing challenges. We also cover the role of automation in cell and gene therapy, trends in antibody drug conjugates, and how catalysts are contributing to a greener future. Brian Mullan of Yposkesi looks at the gaps in gene therapy manufacturing prowess and we also sit down with Gen Li from Phesi.

Download Issue
Register here to download any issue of The Medicine Maker for FREE.
Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Manufacture Process Control

The Human Cost of Poor Practice

| Rob Coker | 2 min read

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

Business & Regulation Digital Technologies

Getting Started With Digitization

| Erin Wright | 4 min read

It’s time for quality and manufacturing to go paperless, but how should a company go about digitization?

Manufacture Small Molecules

Getting to Grips With mRNA

| Catherine Jomary | 4 min read

Walking through the mRNA manufacturing process – and its many challenges.

Manufacture Advanced Medicine

Less Than 5 Percent Human Effort: Thoughts on the Role of Automation on Cell and Gene Therapy

| Dalip Sethi | 7 min read

We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?

Discovery & Development Clinical Trials

Positive Opinion for Regeneron’s Libtayo

| Rob Coker | 3 min read

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

Manufacture Small Molecules

Fighting the Resistance – to Malaria

| Stephanie Sutton | 4 min read

Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?

Discovery & Development Ingredients

Embracing Enzymes

| Ahir Pushpanath | 5 min read

Environmentally friendly catalyst technologies are on the rise in pharma.

Business & Regulation Profession

Welcome Onboard!

| Maryam Mahdi | 5 min read

The pharmaceutical industry is need of young professionals to help close is skill gap. But can companies attract them?

Business & Regulation Profession

A Good Culture Keeps Good People

| Jonathan Thon | 6 min read

Investing in a robust, fulfilling company culture is the best way to thrive in the current challenging recruitment landscape and to achieve long-term

Other issues of 2022